In 2023, the malignant neoplasms mortality rate for females in Japan stood at a baseline from which forecasts for the years 2024 to 2028 indicate a gradual decline. The rates are anticipated to decrease from 124.8 in 2024 to 122.4 in 2028, reflecting a consistent downward trend. The year-on-year percentage changes range from a modest decrease, illustrating ongoing improvements in early diagnosis and treatment.
The Compound Annual Growth Rate (CAGR) over the forecast period highlights a steady decrease in mortality rate, demonstrating an encouraging trend towards better health outcomes for Japanese women.
Future trends to watch for include advancements in cancer treatment technologies, improved healthcare accessibility, and public health initiatives focusing on cancer prevention, which could further accelerate the decline in malignant neoplasms mortality rates.
